In our case series, combination therapy and multiple lines of treatment were used (mAbs, antiviral, CP, mAbs + antiviral, CP + antiviral) (Table 1) due to the severity of the infections and/or the prolonged symptomatic diseases with associated complications. This evidence concerns the gene CP and infection.